AbbVie Inc., a biopharmaceutical company, is dedicated to researching, developing, and marketing both biopharmaceutical and small molecule drugs. AbbVie operates through a single business segment that includes a portfolio of pharmaceutical products.
AbbVie was incorporated on April 10, 2012, and is the result of a spin-off by Abbott Laboratories. It is currently headquartered in North Chicago, Illinois, United States.
Main Product(s):
AbbVie's product line includes a range of pharmaceuticals that target serious chronic conditions and encompass therapeutic areas such as immunology, oncology, neuroscience, virology, and general medicine.
Short History of AbbVie Inc:
April 2012 – AbbVie was incorporated as a separate entity from Abbott Laboratories.
January 2013 – AbbVie officially became an independent company through a spin-off.
2015 – The company acquired Pharmacyclics, enhancing its oncology portfolio.
2020 – AbbVie completed the acquisition of Allergan, marking a significant expansion into new therapeutic areas.
Key developments have also included FDA approvals of several drugs in AbbVie's pipeline, advancing the company's strategic position in the pharmaceutical industry.
Key Executives:
Name
Title
Pay
Exercised
Year Born
Mr. Richard A. Gonzalez
Chairman & CEO
6.95M
N/A
1954
Mr. Robert A. Michael
President & COO
4M
N/A
1970
Mr. Scott T. Reents
Executive VP & CFO
2.97M
N/A
1968
Dr. Azita Saleki-Gerhardt Ph.D.
Executive VP & COO
2.58M
N/A
1963
Mr. Jeffrey Ryan Stewart
Executive VP & Chief Commercial Officer
2.98M
2.78M
1969
Dr. Thomas J. Hudson M.D.
Senior VP of Research & Development and Chief Scientific Officer
N/A
N/A
1962
Ms. Elizabeth Shea
Senior Vice President of Investor Relations
N/A
N/A
N/A
Mr. Sanjay Narayan
VP, Chief Ethics & Compliance Officer
N/A
N/A
N/A
Ms. Tracie Haas
Senior Vice President of Corporate Responsibility, Brand & Communications